| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | L01AB02 |
| UNII: | CO61ER3EPI |
| InChI Key | YCPOZVAOBBQLRI-WDSKDSINSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C6H14O8S2 |
| Molecular Weight | 278.3 |
| AlogP | -2.34 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 127.2 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 16.0 |
| Property Name | Value | Unit | Method |
|---|---|---|---|
| log P (octanol-water) | -3.350 | - | EST |
| Henry's Law Constant | 6.90E-16 | atm-m3/mole | EST |
| Atmospheric OH Rate Constant | 2.30E-11 | cm3/molecule-sec | EST |
| Water Solubility | 1.00E+06 | mg/L | EST |
| Vapor Pressure | 3.80E-10 | mm Hg | EST |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sarcoma, Ewing | 3 | D012512 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 3 | D015470 | ClinicalTrials |
| Myelodysplastic Syndromes | 3 | D009190 | ClinicalTrials |
| Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
| Melanoma | 3 | D008545 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Hodgkin Disease | 2 | D006689 | ClinicalTrials |
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Hematologic Neoplasms | 2 | D019337 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 2 | D008228 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 299-75-2 |
| ChEBI | 82557 |
| ChEMBL | CHEMBL455186 |
| DrugBank | DB11678 |
| DrugCentral | 2718 |
| FDA SRS | CO61ER3EPI |
| Guide to Pharmacology | 8281 |
| KEGG | C19557 |
| PubChem | 9882105 |
| SureChEMBL | SCHEMBL5399430 |
| ZINC | ZINC000001671094 |